Key result
Bromocriptine mesylate yields rapid recovery from neuroleptic malignant syndrome in a single case report.
Why the study?
Neuroleptic malignant syndrome is a relatively uncommon, potentially lethal syndrome with limited success from usual treatments and high mortality.
Does bromocriptine successfully treat neuroleptic malignant syndrome?
Case Report (n=2)
Does bromocriptine successfully treat neuroleptic malignant syndrome?
First reported successful use of bromocriptine mesylate for the treatment of neuroleptic malignant syndrome.
Answers are grounded in this paper and cite their sources.
Single-case success with bromocriptine does not change practice; leaves open its role in neuroleptic malignant syndrome.
THE NEUROLEPTIC malignant syndrome (NMS) is characterized by severe extrapyramidal dysfunction, hyperthermia, and autonomic disturbances following neuroleptic usage.1,2This relatively uncommon, potentially lethal syndrome carries a mortality of 20%, yet it is largely unrecognized by physicians and most workers engaged in the neurosciences. Anticholinergic or benzodiazepine treatment, commonly used for neuroleptic neurological side effects, is usually of limited success in the treatment of NMS; a long hospital course with considerable physical disability often is a result in those patients who survive.3We present two patients with NMS: the first treated in the usual fashion in our medical intensive care unit (ICU), the second on our psychiatric ward, with the rapidly successful and first reported usage of bromocriptine mesylate. Report of Cases Case 1.— A 28-year-old married woman had been well until Feb 2, 1977, when an acute schizophrenic psychosis with paranoia and catatonia rapidly developed. During her first
No takes yet. Share an insight, caveat, or question.
P. S. Mueller (1983) conducted a case report in Neuroleptic malignant syndrome (n=2). Bromocriptine mesylate vs. Usual care was evaluated on Successful treatment. Bromocriptine mesylate was rapidly successful in treating a patient with neuroleptic malignant syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: